For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 1: Heparin Lock | Dialysis Catheter locked with heparin 1,000 units/mL. Heparin 1000U/mL: A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis | 25 | None | 25 | 148 | 0 | 148 | View |
| 2: Gentamicin Lock | Dialysis Catheter locked with gentamicin 320 micrograms/mL in sodium citrate 4%. 4% Sodium Citrate with Gentamicin 320 mcg/mL: A volume sufficient to fill the catheter length will be instilled in both catheter ports post dialysis | 27 | None | 27 | 155 | 0 | 155 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| ESRD Related Death | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |